Cargando…
SOST and DKK: Antagonists of LRP Family Signaling as Targets for Treating Bone Disease
The study of rare human genetic disorders has often led to some of the most significant advances in biomedical research. One such example was the body of work that resulted in the identification of the Low Density Lipoprotein-Related Protein (LRP5) as a key regulator of bone mass. Point mutations we...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
SAGE-Hindawi Access to Research
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951123/ https://www.ncbi.nlm.nih.gov/pubmed/20948575 http://dx.doi.org/10.4061/2010/460120 |